These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 157097)

  • 1. Ampicillin rash and hyperuricemia.
    Murphy TF
    Ann Intern Med; 1979 Aug; 91(2):324. PubMed ID: 157097
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of ampicillin skin reactions by allopurinol or hyperuricemia.
    Jick H; Porter JB
    J Clin Pharmacol; 1981 Oct; 21(10):456-8. PubMed ID: 6458626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess of ampicillin rashes associated with allopurinol or hyperuricemia. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.
    N Engl J Med; 1972 Mar; 286(10):505-7. PubMed ID: 4258181
    [No Abstract]   [Full Text] [Related]  

  • 4. [Skin eruption during combined treatment with ampicilin, amoxicilin and allopurinol].
    Rimon D; Maor N; Kitzes-Cohen R; Cohen L
    Harefuah; 1980 Feb; 98(3):121-3. PubMed ID: 6448779
    [No Abstract]   [Full Text] [Related]  

  • 5. Asymptomatic hyperuricemia and allopurinol induced toxic epidermal necrolysis.
    Renwick IG
    Br Med J (Clin Res Ed); 1985 Aug; 291(6493):485. PubMed ID: 3160433
    [No Abstract]   [Full Text] [Related]  

  • 6. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 7. Ampicillin rashes.
    N Engl J Med; 1972 Jun; 286(22):1217-8. PubMed ID: 4259898
    [No Abstract]   [Full Text] [Related]  

  • 8. Allopurinol and the control of hyperuricemia in neoplastic disease.
    Med Lett Drugs Ther; 1968 Dec; 10(25):103-4. PubMed ID: 5731801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severity and incidence of skin reactions of intolerance to uric acid inhibitors in renal insufficiency].
    Branger B; Méry D; Mion C; Mirouze J
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):596-9. PubMed ID: 137686
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug reactions. XIX. Adverse cutaneous reactions to the penicillins--ampicillin rashes.
    Almeyda J; Levantine A
    Br J Dermatol; 1972 Sep; 87(3):293-7. PubMed ID: 4342950
    [No Abstract]   [Full Text] [Related]  

  • 11. Approach to the treatment of hyperuricemia.
    Poon SH; Hall HA; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
    Navascués RA; Gómez E; Rodriguez M; Laures AS; Baltar J; Grande JA
    Nephron; 2002 May; 91(1):173-4. PubMed ID: 12021539
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allopurinol hypersensitivity. A possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment].
    Urban T; Maquarre E; Housset C; Chouaid C; Devin E; Lebeau B
    Rev Mal Respir; 1995; 12(3):314-6. PubMed ID: 7638430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Allopurinol and bone-marrow depression.
    Shapiro S
    Lancet; 1974 Aug; 2(7877):412. PubMed ID: 4136857
    [No Abstract]   [Full Text] [Related]  

  • 15. Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
    Liu C; Zhao Q; Zhen Y; Gao Y; Tian L; Wang L; Ji L; Liu G; Ji Z; Liu K
    Can J Cardiol; 2013 Sep; 29(9):1048-54. PubMed ID: 23395281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of Allomaron in treating hyperuricemia].
    Balkarov IM
    Ter Arkh; 1994; 66(1):40-2. PubMed ID: 8146793
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of febuxostat in patients with allopurinol-refractory hyperuricemic chronic kidney disease
.
    Kwak CH; Sohn M; Han N; Cho YS; Kim YS; Oh JM
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):321-327. PubMed ID: 29750634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milurit's place in therapy.
    Gömör B; Szebenyi B
    Ther Hung; 1990; 38(1):13-21. PubMed ID: 2189231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5.
    Liu X; Wang H; Ma R; Shao L; Zhang W; Jiang W; Luo C; Zhai T; Xu Y
    Clin Exp Nephrol; 2019 Mar; 23(3):362-370. PubMed ID: 30291473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol in the treatment of neoplastic disease complicated by hyperuricemia.
    Muggia FM; Ball TJ; Ultmann JE
    Arch Intern Med; 1967 Jul; 120(1):12-8. PubMed ID: 6028692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.